Kimberly-Clark Announces 4.5 Percent Dividend Increase
Company Raises Dividend for 44th Consecutive Year
Get Alerts KMB Hot Sheet
Join SI Premium – FREE
DALLAS, Feb. 11, 2016 /PRNewswire/ -- Kimberly-Clark Corporation (NYSE: KMB) today announced its board of directors has approved a dividend increase of 4.5 percent. This will bring the quarterly dividend to $.92 per share, up from $.88 per share in 2015.
The board of directors declared the dividend payable on April 4, 2016 to stockholders of record on March 4, 2016. This is the 44th consecutive year Kimberly-Clark has raised its dividend and the 82nd straight year the company has paid dividends.
"Kimberly-Clark remains committed to deliver strong returns to our investors and to allocate capital in shareholder-friendly ways," said Thomas J. Falk, chairman and chief executive officer. "We continue to provide a top-tier dividend payout among our peer consumer packaged goods companies."
About Kimberly-Clark
Kimberly-Clark (NYSE: KMB) and its well-known global brands are an indispensable part of life for people in more than 175 countries. Every day, nearly a quarter of the world's population trust K-C's brands and the solutions they provide to enhance their health, hygiene and well-being. With brands such as Kleenex, Scott, Huggies, Pull-Ups, Kotex and Depend, Kimberly-Clark holds No. 1 or No. 2 share positions in more than 80 countries. To keep up with the latest K-C news and to learn more about the Company's 144-year history of innovation, visit www.kimberly-clark.com or follow us on Facebook or Twitter.
[KMB-F]
Logo - http://photos.prnewswire.com/prnh/20110928/DA76879LOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/kimberly-clark-announces-45-percent-dividend-increase-300218990.html
SOURCE Kimberly-Clark Corporation
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Piper Sandler on Kimberly Clark (KMB): 'Deal Dynamics Look Better Than Advertised'
- FRACTAL Discloses Mesh-to-Gateway System for Part 15 D2D Satellite Connectivity
- Merck and Moderna's melanoma drug combo beats Keytruda alone in trial
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
Twitter, DividendSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share